| Literature DB >> 32063907 |
Yanjing Guo1, Jing Cheng1, Yuping Lu1, He Wang1, Yazhi Gao1, Jiale Shi1, Cancan Yin1, Xiaoxiong Wang1, Shiguo Chen1, Reto Jörg Strasser1,2, Sheng Qiang1.
Abstract
Gliotoxin (GT) is a fungal secondary metabolite that has attracted great interest due to its high biological activity since it was discovered by the 1930s. It exhibits a unique structure that contains a N-C = O group as the characteristics of the classical PSII inhibitor. However, GT's phytotoxicity, herbicidal activity and primary action targets in plants remain hidden. Here, it is found that GT can cause brown or white leaf spot of various monocotyledonous and dicotyledonous plants, being regarded as a potential herbicidal agent. The multiple sites of GT action are located in two photosystems. GT decreases the rate of oxygen evolution of PSII with an I 50 value of 60 µM. Chlorophyll fluorescence data from Chlamydomonas reinhardtii cells and spinach thylakoids implicate that GT affects both PSII electron transport at the acceptor side and the reduction rate of PSI end electron acceptors' pool. The major direct action target of GT is the plastoquinone QB-site of the D1 protein in PSII, where GT inserts in the QB binding niche by replacing native plastoquinone (PQ) and then interrupts electron flow beyond plastoquinone QA. This leads to severe inactivation of PSII RCs and a significant decrease of PSII overall photosynthetic activity. Based on the simulated modeling of GT docking to the D1 protein of spinach, it is proposed that GT binds to the-QB-site through two hydrogen bonds between GT and D1-Ser264 and D1-His252. A hydrogen bond is formed between the aromatic hydroxyl oxygen of GT and the residue Ser264 in the D1 protein. The 4-carbonyl group of GT provides another hydrogen bond to the residue D1-His252. So, it is concluded that GT is a novel natural PSII inhibitor. In the future, GT may have the potential for development into a bioherbicide or being utilized as a lead compound to design more new derivatives.Entities:
Keywords: D1 protein; action target; binding model; chlorophyll a fluorescence (OJIP) transient; mycotoxin
Year: 2020 PMID: 32063907 PMCID: PMC6999049 DOI: 10.3389/fpls.2019.01688
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Formulae and explanation of the technical data of the OJIP curves and the selected JIP-test parameters used in this studya.
|
| |
| Ft | fluorescence at time t after onset of actinic illumination |
| FO ≅ F20µs | minimal fluorescence, when all PSII RCs are open |
| FL ≡ F150µs | fluorescence intensity at the L-step (150 µs) of OJIP |
| FK ≡ F300µs | fluorescence intensity at the K-step (300 µs) of OJIP |
| FJ ≡ F2ms | fluorescence intensity at the J-step (2 ms) of OJIP |
| FI ≡ F30ms | fluorescence intensity at the I-step (30 ms) of OJIP |
| FP (= FM) | maximal recorded fluorescence intensity, at the peak P of OJIP |
| Fv ≡ Ft – FO | variable fluorescence at time t |
| FV ≡ FM – FO | maximal variable fluorescence |
| tFM | time (in ms) to reach the maximal fluorescence intensity FM |
| Vt ≡ (Ft – FO)/(FM – FO) | relative variable fluorescence at time t |
| VK = (FK – FO)/(FM – FO) | relative variable fluorescence at the K-step |
| VJ = (FJ – FO)/(FM – FO) | relative variable fluorescence at the J-step |
| Wt ≡ (Ft – FO)/(FJ – FO) | relative variable fluorescence Fv to the amplitude FJ – FO |
| WOK = (Ft – FO)/(FK – FO) | ratio of variable fluorescence Ft – FO to the amplitude FK – FO |
| WOJ = (Ft – FO)/(FJ – FO) | ratio of variable fluorescence Ft – FO to the amplitude FJ – FO |
| WOI = (Ft – FO)/(FI – FO) | ratio of variable fluorescence Ft – FO to the amplitude FI – FO |
| WIP = (Ft – FI)/(FP – FI) | ratio of variable fluorescence Ft – FI to the amplitude FP– FI |
| M0 ≡ 4(F270μs – FO)/(FM – FO) | approximated initial slope (in ms–1) of the fluorescence transient normalized on the maximal variable fluorescence FV |
| Sm ≡ Area/(FM – FO) | normalized total complementary area above the O-J-I-P transient (reflecting multiple-turnover QA reduction events) |
| Ss = VJ/M0 | normalized total complementary area corresponding only to the O-J phase (reflecting single-turnover QA reduction events) |
|
| |
| φPo = PHI(P0) = TR0/ABS = 1– FO/FM | maximum quantum yield for primary photochemistry |
| ψEo = PSI0 = ET0/TR0 = 1–VJ | probability that an electron moves further than |
| φEo = PHI(E0) = ET0/ABS = (1– FO/FM) (1–VJ) | quantum yield for electron transport (ET) |
| φDo = PHI(D0) = 1- φPo = FO/FM | quantum yield (at t = 0) of energy dissipation |
| φRo = RE0/ABS = φPo. ψEo. δRo = φPo. (1–VI) | quantum yield for reduction of the end electron acceptors at the PSI acceptor side (RE) |
| δRo = RE0/ET0 = (1 – VI)/(1 – VJ) | probability that an electron is transported from the reduced intersystem electron acceptors to the final electron acceptors of PSI |
| γRC = ChlRC/Chltotal = RC/(ABS+RC) | probability that a PSII Chl molecule functions as RC |
|
| |
| ABS/CS = Chl/CS | absorption flux per CS |
| TR0/CS = φPo. (ABS/CS) | trapped energy flux per CS |
| ET0/CS = φPo. ψEo. (ABS/CS) | electron transport flux per CS |
|
| |
| RC/CS = φPo. (VJ/M0). (ABS/CS) | QA-reducing RCs per CS |
| QA-reducing centers = (RC/RCreference).(ABS/ABSreference) = [(RC/CS)treatment/(RC/CS)control]. [(ABS/CS)treatment/(ABS/CS)control] | The fraction of QA-reducing reaction centers |
| Non-QA-reducing centers = 1- QA-reducing centers | The fraction of non-QA-reducing reaction centers, also so-called heat sink centers or silent centers |
| Sm/tFM = [RCopen/(RCclose + RCopen)]av = [QA/QA(total)]av | average fraction of open RCs of PSII in the time span between 0 to |
| RJ = [ψEo (control) − ψEo (treatment)]/ψEo (control) = [VJ (treatment) – VJ (control)]/[1 − VJ (control)] | number of PSII RCs with QB-site filled by PSII inhibitor |
|
| |
|
| performance index (potential) for energy conservation from photons absorbed by PSII to the reduction of intersystem electron acceptors |
|
| performance index (potential) for energy conservation from photons absorbed by PSII to the reduction of PSI end acceptors |
Subscript “0” (or “o” when written after another subscript) indicates that the parameter refers to the onset of illumination, when all RCs are assumed to be open.
Figure 1Disease development of the detached-leaves with Gliotoxin (GT). Leaves from 10 different plant species were treated without (1% DMSO as control, red circles on the right side) or with GT at various concentrations (100, 500, and 1,000 µM). Lesion photographs were taken at 96 h. Lesion diameter and pathogenicity level were analyzed in .
Phytotoxicity of Gliotoxin (GT) to various plantsa.
| Family | Plant species | GT concentration (µM) | Lesion diameter (mm) | Pathogenicity levelb |
|---|---|---|---|---|
| Gramineae |
| 100 | 0.61 ± 0.15 | + |
| 500 | 2.24 ± 0.16 | ++ | ||
| 1,000 | 2.59 ± 0.09 | ++ | ||
|
| 100 | 2.49 ± 0.13 | ++ | |
| 500 | 3.06 ± 0.10 | +++ | ||
| 1,000 | 4.23 ± 0.66 | +++ | ||
|
| 100 | 2.10 ± 0.16 | ++ | |
| 500 | 3.60 ± 0.83 | +++ | ||
| 1,000 | 5.49 ± 0.29 | +++ | ||
|
| 100 | 1.29 ± 0.09 | ++ | |
| 500 | 2.09 ± 0.07 | ++ | ||
| 1,000 | 2.10 ± 0.07 | ++ | ||
| Compositae |
| 100 | 2.10 ± 0.67 | ++ |
| 500 | 3.19 ± 1.51 | +++ | ||
| 1,000 | 3.60 ± 0.69 | +++ | ||
|
| 100 | 3.88 ± 0.34 | +++ | |
| 500 | 5.94 ± 1.17 | +++ | ||
| 1,000 | 7.25 ± 1.69 | +++ | ||
|
| 100 | 1.68 ± 0.13 | ++ | |
| 500 | 3.04 ± 0.21 | +++ | ||
| 1,000 | 3.78 ± 0.22 | +++ | ||
| Oxalidaceae |
| 100 | 2.55 ± 0.08 | ++ |
| 500 | 3.79 ± 0.24 | +++ | ||
| 1,000 | 4.20 ± 0.29 | +++ | ||
| Solanaceae |
| 100 | 1.58 ± 0.10 | ++ |
| 500 | 2.87 ± 0.60 | ++ | ||
| 1,000 | 4.84 ± 2.05 | +++ | ||
| Malvaceae |
| 100 | 1.63 ± 0.18 | ++ |
| 500 | 1.96 ± 0.11 | ++ | ||
| 1,000 | 2.61 ± 0.17 | ++ |
aThe detached-intact leaves from different plant species are rinsed with sterilized water, subsequently dried and placed in Petri dishes with wet filter paper. The leaves were lightly punctured using a needle from the leaf margin on the abaxial side. Ten microliter of GT solution was dripped onto the punctured wound. All Petri dishes were placed in the growth chamber for 96 h at 25°C under around 200 µmol m−2 s−1 white light (day/night, 12 h/12 h). Diameter of leaf lesion was measured with calipers. Each value is the average of three independent experiments. b +, ++, +++ denotes leaf lesion diameter 0 to <1.0 mm, 1.0 to <3.0 mm, and ≥3.0 mm, respectively.
Figure 2Effect of Gliotoxin (GT) and DCMU on the rate of O2 evolution of C. reinhardtii cells. H2O and p-phenylenediamine is the electron donor and acceptor, respectively. Data shown are mean values ± SE of 3 times independent measurements.
Figure 3Effect of Gliotoxin (GT) on color fluorescence imaging (A) the value of the maximum quantum yield of PSII (FV/FM), electron transport rate (ETR), Yield and qP (B) of C. reinhardtii cells. Fluorescence images were indicated by color code in the order of black (0) through red, orange, yellow, green, blue, violet to purple (1). The number codes above images are marked from 0 to 1, showing the changes. Each value is the average ± SE of three independent experiments.
Figure 4Chl a fluorescence rise kinetics of C. reinhardtii cells treated with 1% DMSO (mock), DCMU (1 μM), and Gliotoxin (GT) at the indicated concentrations. (A) Raw fluorescence rise kinetics. (B) Fluorescence rise kinetics normalized by FO and FM as Vt = (Ft − FO)/(FM−FO) (top), and ΔVt = Vt(treated) − Vt(control) (bottom). (C) Fluorescence rise kinetics normalized by FO and FK as WOK = (Ft − FO)/(FK − FO) (top), and the difference kinetics ΔWOK = WOK(treated) − WOK(control) (bottom). (D) Fluorescence rise kinetics normalized by FO and FJ as WOJ = (Ft − FO)/(FJ − FO) (top), and the difference kinetics ΔWOJ = WOJ(treated) − WOJ(control) (bottom). (E) Fluorescence rise kinetics normalized by FO and FI as WOI = (Ft − FO)/(FI − FO). (F) Fluorescence rise kinetics normalized by FI and FP as WIP = (Ft − FI)/(FP − FI) and WOI (≥1) in the insert, the half-times are shown by the crossing of the curves with the horizontal dashed line drawn at WIP = 0.5 (half rise). Each curve is the average of 30 measurements.
Figure 5Spider plot presentation of selected parameters derived from JIP-test quantifying PSII behavior of C. reinhardtii cells treated with various concentrations of GT. Each parameter is expressed as fraction relatively to the values of the control (mock, back regular circle with value 100% = 1).
Figure 6Effect of Gliotoxin (GT) on the kinetics of modulated reflection at 820 nm (MR). (A) A graphical definition of the characteristic parameters of the MR kinetics. Here, MR0 is the value at the onset of the actinic illumination (taken at 0.7 ms, the first reliable MR measurement), MRmin is the minimal signal reached during the fast phase between 0.7 ms and 10–200 ms, MRmax is the maximal signal reached by the end of the slow phase (usually taken at 1 to 2 s). (B) The MR induction curves of C. reinhardtii cells treated with 1% DMSO (mock), MV (200 µM), DCMU (1 μM), and GT (100, 200 µM). The plotted values are expresses by the MR/MR0 ratio. Each curve is the average of 30 measurements.
Figure 7Effect of Gliotoxin (GT) on spinach thylakoids. (A) Raw fluorescence rise kinetics of thylakoids treated with 1% DMSO (mock), DCMU (1 μM), and GT at the indicated concentrations for 0.5 h. (B) Fluorescence rise kinetics normalized by FO and FM as Vt = (Ft − FO)/(FM−FO). (C) Radar plot presenting the JIP-test parameters from thylakoids with different concentrations of GT. (D) The concentration-dependent change of RJ. The parameter RJ reflects the number of PSII RCs with their QB site filled by PSII inhibitors (here is GT). (E) Analysis of the correlation for VJ, PIABS, and Sm/tFM versus φEo of spinach thylakoids treated with GT at different concentration (mock, 50, 100, 200, and 400 μM). (F) Analysis of the linear relationship between Sm/tFM and RJ after spinach thylakoids were treated with GT. Each value is the average of 30 measurements.
Figure 8The simulated modeling of atrazine binding to the QB-site. (A) Stereo view of atrazine binding environment of the L-subunit of Rps. viridis (left) and the D1 protein of S. oleracea (right). (B) Hydrogen bonding interactions for atrazine binding to the QB niche. Here, carbon atoms are shown in grey, nitrogen atoms in blue, oxygen in red, chlorine in green, and hydrogen atoms in white. The possible hydrogen bonds are indicated by dashed lines. (C) Sequence alignment of the Dl protein of C. reinhardtii and S. oleracea with the L-subunit of the Rps. viridis RC. The bacterial L-subunit sequences are in upper case and the Dl sequence is in lower case.
Possible hydrogen bonding interactions for atrazine, DCMU and Gliotoxin (GT) binding to the L-subunit of Rh. viridis or the D1 protein of S. oleracea. The circle refers to the predicted atom position providing hydrogen bond with the indicated amino acid residue.
| Com. | Mol. Formula | Chemical Structure | Binding target | Hydrogen Bound Position | |
|---|---|---|---|---|---|
| atrazine | C8H14ClN5 |
| L-subunit |
|
|
|
| D1 |
|
| ||
| DCMU | C9H10Cl2N2O |
| D1 |
|
|
| gliotoxin | C13H14N2O4S2 |
| D1 |
|
|
Figure 9The simulated modeling of DCMU and Gliotoxin (GT) binding to the D1 protein of S. oleracea. (A) Stereo view of DCMU (left) and GT (right) binding environment of S. oleracea D1 protein. (B) Hydrogen bonding interactions for DCMU (left) and GT (right) binding to the D1 protein. Here, carbon atoms are shown in grey, nitrogen atoms in blue, oxygen in red, chlorine in green, and hydrogen atoms in white. The possible hydrogen bonds are indicated by dashed lines.